SP-7676

N/A

Report date: 2023/12/28 17:26:18

Base Information

Drug NameSP-7676
Drug Alias NameSP-7676
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-CD74
TargetsHLA-DR antigens-associated invariant chain
Therapy Area/IndicationsLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSutro Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesSutro Biopharma Inc
Inactive CompaniesN/A
Active IndicationsLymphoma, Non-Hodgkin
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A